The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: JPMorgan Raises Man Group And Sanne

Thu, 10th Dec 2020 10:16

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

BERENBERG RAISES CRODA INTERNATIONAL TO 'BUY' ('HOLD') - TARGET 7,200 (6,000) PENCE

----------

MORGAN STANLEY CUTS AVAST PRICE TARGET TO 610 (650) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES VODAFONE PRICE TARGET TO 205 (200) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES RIO TINTO PRICE TARGET TO 5,200 (4,290) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES GLENCORE PRICE TARGET TO 274 (215) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EVRAZ PRICE TARGET TO 430 (410) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES BHP GROUP PRICE TARGET TO 1,960 (1,680) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES ANTOFAGASTA TARGET TO 1,305 (1,030) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES ANGLO AMERICAN TARGET TO 2,780 (2,280) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES SAGE GROUP TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 610 PENCE

----------

JPMORGAN RAISES DS SMITH PRICE TARGET TO 408 (340) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES ASHTEAD GROUP PRICE TARGET TO 3,000 (2,150) PENCE - 'HOLD'

----------

BERENBERG RAISES POLYMETAL PRICE TARGET TO 2,580 (2,560) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES RIO TINTO PRICE TARGET TO 5,645 (4,685) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES BHP GROUP PRICE TARGET TO 2,360 (2,020) PENCE - 'BUY'

----------

JPMORGAN RAISES STANDARD LIFE ABERDEEN TARGET TO 315 (270) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES SCHRODERS PRICE TARGET TO 3,175 (2,800) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES INTERMEDIATE CAPITAL TARGET TO 2,000 (1,950) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS HARGREAVES LANSDOWN TARGET TO 1,390 (1,470) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS BUNZL TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 2,800 PENCE

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 8,500 (8,100) PENCE - 'HOLD'

----------

FTSE 250

----------

JPMORGAN RAISES SANNE GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 670 PENCE

----------

JPMORGAN RAISES MAN GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 150 (140) PENCE

----------

UBS RAISES VICTREX PRICE TARGET TO 1,750 (1,625) PENCE - 'SELL'

----------

MORGAN STANLEY CUTS CENTAMIN PRICE TARGET TO 125 (130) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN RAISES INCHCAPE PRICE TARGET TO 708 (645) PENCE - 'OVERWEIGHT'

----------

BERENBERG CUTS WORKSPACE GROUP TO 'SELL' ('HOLD') - TARGET 670 (590) PENCE

----------

BARCLAYS RAISES VICTREX TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TARGET 1,980 (1,710) PENCE

----------

BARCLAYS CUTS SERCO GROUP PRICE TARGET TO 150 (165) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES BABCOCK INTERNATIONAL TARGET TO 290 (255) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES QUILTER PRICE TARGET TO 180 (170) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES JUPITER FUND PRICE TARGET TO 310 (300) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ASHMORE GROUP PRICE TARGET TO 385 (360) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES HOWDEN JOINERY GROUP TARGET TO 677 (641) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS SERCO GROUP PRICE TARGET TO 170 (180) PENCE - 'OVERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES CERES POWER PRICE TARGET TO 1220 (1060) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STAGECOACH PRICE TARGET TO 86 (72) PENCE - 'BUY'

----------

BERENBERG CUTS PETRA DIAMONDS PRICE TARGET TO 2 (3) PENCE - 'HOLD'

----------

BERENBERG RAISES GRIFFIN MINING PRICE TARGET TO 115 (105) PENCE - 'BUY'

----------

BERENBERG RAISES GEM DIAMONDS PRICE TARGET TO 51 (43) PENCE - 'BUY'

----------

BERENBERG RAISES CENTRAL ASIA METALS PRICE TARGET TO 250 (234) PENCE - 'BUY'

----------

BERENBERG CUTS ANGLO PACIFIC GROUP PRICE TARGET TO 140 (150) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.